Kurt H. Kruger, Director at Qualigen Therapeutics, Inc. (QLGN), bought 4,000 shares at $2.94 ($12K) on 2020-12-29, disclosed to the SEC on 2020-12-30.
Open-market purchase of $12k QLGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |